Information about Belipharm
My details
*
*
*

Belipharm (SPRL)

BE

0884.446.592

Company information

Status
Active

Enterprise number

BE0884.446.592

VAT liability
Yes
Established
04-10-2006
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société privée à responsabilité limitée (SPRL)
Principal activity
Wholesale of pharmaceutical and medical goods
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Belipharm

2025 2024 2023 2022
Income statement
Profit/Loss € 22,885 3% € 22,240 -51% € 45,049 109% € 21,568
Gross margin € 36,326 30% € 28,038 -41% € 47,343 89% € 25,046
Balance sheet
Balance sheet total € 449,785 216% € 142,510 -2% € 146,098 571% € 21,789
Equity € 35,863 176% € 12,978 240% € -9,262 83% € -54,311
Debts € 413,922 220% € 129,532 -17% € 155,360 104% € 76,100

Publications from Belipharm

Date Publication
06-07-2015 Resignations - Appointments (NL)
04-11-2013 Registered Office (NL)
30-10-2006 Constitution (NL)

Frequently asked questions

What is the VAT number of Belipharm?
The VAT number of Belipharm is BE 0884.446.592.
Wat is the PEPPOL ID of Belipharm?
The PEPPOL ID of Belipharm is 0208:0884446592. Log in or start a free trial to see the full overview.
When was Belipharm founded?
Belipharm was founded on 04-10-2006.
What is the address of Belipharm?
The current registered office of Belipharm is located at Herestraat 13, 3000 Leuven.
When was the last time Belipharm filed their annual financial statements?
The most recent financial statements of Belipharm were filed on 09-06-2026.
How many employees does Belipharm have?
There are currently no employees working at Belipharm or no workforce information is available.
What is the annual turnover of Belipharm?
At the time of its most recent financial statements, Belipharm did not publish any turnover figures. Belipharm reported a gross margin of €36,325.81.

Sources